The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Stefan H. Hohnloser

J.W. Goethe University


Germany. Electronic address:


Name/email consistency: high



  • J.W. Goethe University, Frankfurt, Germany. Electronic address:. 1998 - 2012
  • Stefan H. Hohnloser, MD, FACC, FESC, FHRS, Division of Clinical Electrophysiology, J. W. Goethe University Hospital, E-mail:. 2010 - 2012


  1. Atrial overdrive pacing to prevent atrial fibrillation: Insights from ASSERT. Hohnloser, S.H., Healey, J.S., Gold, M.R., Israel, C.W., Yang, S., van Gelder, I., Capucci, A., Lau, C.P., Fain, E., Morillo, C.A., Ha, A., Carlson, M., Connolly, S.J. Heart. Rhythm (2012) [Pubmed]
  2. Dabigatran for stroke prevention in atrial fibrillation. Hohnloser, S.H., Diener, H.C. Hamostaseologie (2012) [Pubmed]
  3. Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial. Hohnloser, S.H., Oldgren, J., Yang, S., Wallentin, L., Ezekowitz, M., Reilly, P., Eikelboom, J., Brueckmann, M., Yusuf, S., Connolly, S.J. Circulation (2012) [Pubmed]
  4. Benefit-risk assessment of current antiarrhythmic drug therapy of atrial fibrillation. Hohnloser, S.H. Clin. Cardiol (2012) [Pubmed]
  5. Dronedarone in patients with congestive heart failure: insights from ATHENA. Hohnloser, S.H., Crijns, H.J., van Eickels, M., Gaudin, C., Page, R.L., Torp-Pedersen, C., Connolly, S.J. Eur. Heart J. (2010) [Pubmed]
  6. Effect of dronedarone on cardiovascular events in atrial fibrillation. Hohnloser, S.H., Crijns, H.J., van Eickels, M., Gaudin, C., Page, R.L., Torp-Pedersen, C., Connolly, S.J. N. Engl. J. Med. (2009) [Pubmed]
  7. Evidence regarding clinical use of microvolt T-wave alternans. Hohnloser, S.H., Ikeda, T., Cohen, R.J. Heart. Rhythm (2009) [Pubmed]
  8. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter. Hohnloser, S.H., Connolly, S.J., Crijns, H.J., Page, R.L., Seiz, W., Torp-Petersen, C. J. Cardiovasc. Electrophysiol. (2008) [Pubmed]
  9. Risk factor assessment: defining populations and individuals at risk. Hohnloser, S.H. Cardiol. Clin (2008) [Pubmed]
  10. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Hohnloser, S.H., Pajitnev, D., Pogue, J., Healey, J.S., Pfeffer, M.A., Yusuf, S., Connolly, S.J. J. Am. Coll. Cardiol. (2007) [Pubmed]
  11. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Hohnloser, S.H., Dorian, P., Roberts, R., Gent, M., Israel, C.W., Fain, E., Champagne, J., Connolly, S.J. Circulation (2006) [Pubmed]
  12. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). Hohnloser, S.H., Capucci, A., Fain, E., Gold, M.R., van Gelder, I.C., Healey, J., Israel, C.W., Lau, C.P., Morillo, C., Connolly, S.J. Am. Heart J. (2006) [Pubmed]
  13. Can microvolt T-wave alternans predict mortality in patients with ischemic cardiomyopathy?. Hohnloser, S.H. Nature Clinical Practice. Cardiovascular Medicine (2006) [Pubmed]
  14. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Hohnloser, S.H., Al-Khalidi, H.R., Pratt, C.M., Brum, J.M., Tatla, D.S., Tchou, P., Dorian, P. Eur. Heart J. (2006) [Pubmed]
  15. Ventricular arrhythmias: antiadrenergic therapy for the patient with coronary artery disease. Hohnloser, S.H. J. Cardiovasc. Pharmacol. Ther. (2005) [Pubmed]
  16. Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter. Hohnloser, S.H., Dorian, P., Straub, M., Beckmann, K., Kowey, P. J. Am. Coll. Cardiol. (2004) [Pubmed]
  17. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. Hohnloser, S.H., Kuck, K.H., Dorian, P., Roberts, R.S., Hampton, J.R., Hatala, R., Fain, E., Gent, M., Connolly, S.J. N. Engl. J. Med. (2004) [Pubmed]
  18. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. Hohnloser, S.H., Klingenheben, T., Bloomfield, D., Dabbous, O., Cohen, R.J. J. Am. Coll. Cardiol. (2003) [Pubmed]
  19. Combined antiplatelet therapy in atrial fibrillation: review of the literature and future avenues. Hohnloser, S.H., Connolly, S.J. J. Cardiovasc. Electrophysiol. (2003) [Pubmed]
  20. The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol. Hohnloser, S.H., Connolly, S.J., Kuck, K.H., Dorian, P., Fain, E., Hampton, J.R., Hatala, R., Pauly, A.C., Roberts, R.S., Themeles, E., Gent, M. Am. Heart J. (2000) [Pubmed]
  21. Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Hohnloser, S.H., Kuck, K.H., Lilienthal, J. Lancet (2000) [Pubmed]
  22. Macroscopic T wave alternans as a harbinger of sudden death. Hohnloser, S.H. J. Cardiovasc. Electrophysiol. (1999) [Pubmed]
  23. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. Hohnloser, S.H., Klingenheben, T., Zabel, M., Schöpperl, M., Mauss, O. J. Am. Coll. Cardiol. (1999) [Pubmed]
  24. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. Hohnloser, S.H., Klingenheben, T., Li, Y.G., Zabel, M., Peetermans, J., Cohen, R.J. J. Cardiovasc. Electrophysiol. (1998) [Pubmed]
WikiGenes - Universities